The Safe Fast Track Study
NCT06219486 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1538
Last updated 2025-04-09
Summary
Emergency departments (ED) internationally are treating an increasing number of patients.
Most require hospital services but some could be better cared for on alternative pathways.
D-dimer has some unique properties. It is non-specific and is elevated in many acute condi- tions; but conversely remains normal in the absence of significant disease. Previous studies have shown that having a normal D-dimer on arrival to the emergency department is associated with a very low risk of 30-day all-cause mortality.
The investigators propose a multicenter randomized controlled trial using D-dimer to identify patients at low risk and test if providing this information will change time to discharge disposition by the treating physician.
Conditions
- Emergency Department
- Non-specific Complaints
Interventions
- DIAGNOSTIC_TEST
-
D-dimer
The investigators will measure a D-dimer test on participants and randomize on informing the physician on the value.
Sponsors & Collaborators
-
Slagelse Sygehus
collaborator OTHER -
Holbaek Sygehus
collaborator OTHER -
Esbjerg Hospital - University Hospital of Southern Denmark
collaborator OTHER -
Odense University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-22
- Primary Completion
- 2025-07-01
- Completion
- 2025-08-01
Countries
- Denmark
Study Locations
More Related Trials
-
Deep Venous Thrombosis and Long Term Complications
NCT05789108 ·Status: RECRUITING ·Phase: NA
-
A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay
NCT04737954 ·Status: UNKNOWN ·Phase: NA
-
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
NCT04088292 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
MDA D-Dimer / Recurrent DVT Study
NCT00157599 ·Status: COMPLETED ·Phase: NA
-
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
NCT00720915 ·Status: COMPLETED ·Phase: NA
-
D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
NCT00264277 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19
NCT05185804 ·Status: COMPLETED ·Phase: PHASE3
-
Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)
NCT00157677 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Emergency Department Testing for Deep Vein Thrombosis
NCT06195787 ·Status: COMPLETED
-
Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation
NCT00860106 ·Status: COMPLETED ·Phase: PHASE4
-
Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study
NCT02486445 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
NCT04741464 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
NCT03129555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
NCT05794165 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Below Knee DVT Study
NCT03805672 ·Status: TERMINATED ·Phase: PHASE4
-
D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism
NCT00428441 ·Status: TERMINATED ·Phase: NA
-
D-Dimer and IPG for Recurrent Thrombosis (DIRECT)
NCT00182247 ·Status: TERMINATED ·Phase: PHASE3
-
Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis
NCT00251771 ·Status: COMPLETED ·Phase: NA
-
Treatment for Blood Clots in the Veins of the Legs
NCT00001713 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of the Coagulopathy Developed by COVID-19 Infected Patients
NCT04356950 ·Status: COMPLETED
-
Study of Low Molecular Weight Heparins
NCT06020560 ·Status: UNKNOWN ·Phase: PHASE4
-
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
NCT04862468 ·Status: RECRUITING ·Phase: PHASE2
-
Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
NCT00082355 ·Status: COMPLETED ·Phase: PHASE2
-
D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD
NCT03261284 ·Status: UNKNOWN ·Phase: NA